166 related articles for article (PubMed ID: 20204405)
1. Targeting monoamine oxidase A in advanced prostate cancer.
Flamand V; Zhao H; Peehl DM
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1761-71. PubMed ID: 20204405
[TBL] [Abstract][Full Text] [Related]
2. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
[TBL] [Abstract][Full Text] [Related]
3. Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells.
Zhao H; Flamand V; Peehl DM
BMC Med Genomics; 2009 Aug; 2():55. PubMed ID: 19691856
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.
Wu JB; Lin TP; Gallagher JD; Kushal S; Chung LW; Zhau HE; Olenyuk BZ; Shih JC
J Am Chem Soc; 2015 Feb; 137(6):2366-74. PubMed ID: 25585152
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.
Wu JB; Shao C; Li X; Li Q; Hu P; Shi C; Li Y; Chen YT; Yin F; Liao CP; Stiles BL; Zhau HE; Shih JC; Chung LW
J Clin Invest; 2014 Jul; 124(7):2891-908. PubMed ID: 24865426
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration.
Jacobs MR; Olivero JE; Ok Choi H; Liao CP; Kashemirov BA; Katz JE; Gross ME; McKenna CE
Bioorg Med Chem; 2023 Sep; 92():117425. PubMed ID: 37544256
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells.
Zhao H; Nolley R; Chen Z; Reese SW; Peehl DM
Differentiation; 2008 Sep; 76(7):820-30. PubMed ID: 18248494
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.
Li PC; Siddiqi IN; Mottok A; Loo EY; Wu CH; Cozen W; Steidl C; Shih JC
J Pathol; 2017 Oct; 243(2):220-229. PubMed ID: 28722111
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase A drives neuroendocrine differentiation in prostate cancer.
Shui X; Ren X; Xu R; Xie Q; Hu Y; Qin J; Meng H; Zhang C; Zhao J; Shi C
Biochem Biophys Res Commun; 2022 May; 606():135-141. PubMed ID: 35349822
[TBL] [Abstract][Full Text] [Related]
10. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors.
Ma J; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
J Mol Biol; 2004 Apr; 338(1):103-14. PubMed ID: 15050826
[TBL] [Abstract][Full Text] [Related]
11. MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.
Lin YC; Chang YT; Campbell M; Lin TP; Pan CC; Lee HC; Shih JC; Chang PC
Sci Rep; 2017 Apr; 7():46338. PubMed ID: 28402333
[TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy.
Han H; Li H; Ma Y; Zhao Z; An Q; Zhao J; Shi C
Cancer Lett; 2023 Jun; 563():216188. PubMed ID: 37076041
[TBL] [Abstract][Full Text] [Related]
13. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.
Xu S; Adisetiyo H; Tamura S; Grande F; Garofalo A; Roy-Burman P; Neamati N
Br J Cancer; 2015 Jul; 113(2):242-51. PubMed ID: 26103574
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.
Lv Q; Yang X; Wang M; Yang J; Qin Z; Kan Q; Zhang H; Wang Y; Wang D; He Z
J Control Release; 2018 Jun; 279():234-242. PubMed ID: 29679664
[TBL] [Abstract][Full Text] [Related]
16. The significance of monoamine oxidase-A expression in high grade prostate cancer.
Peehl DM; Coram M; Khine H; Reese S; Nolley R; Zhao H
J Urol; 2008 Nov; 180(5):2206-11. PubMed ID: 18804811
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes.
Gordon RR; Wu M; Huang CY; Harris WP; Sim HG; Lucas JM; Coleman I; Higano CS; Gulati R; True LD; Vessella R; Lange PH; Garzotto M; Beer TM; Nelson PS
PLoS One; 2014; 9(9):e104271. PubMed ID: 25198178
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and preliminary crystallographic analysis of rat monoamine oxidase A complexed with clorgyline.
Ma J; Kubota F; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):317-9. PubMed ID: 14747710
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitorsâ»Indocyanine Dyes Conjugates as Targeted Antitumor Agents.
Yang XG; Mou YH; Wang YJ; Wang J; Li YY; Kong RH; Ding M; Wang D; Guo C
Molecules; 2019 Apr; 24(7):. PubMed ID: 30974737
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling.
Li J; Yang XM; Wang YH; Feng MX; Liu XJ; Zhang YL; Huang S; Wu Z; Xue F; Qin WX; Gu JR; Xia Q; Zhang ZG
J Hepatol; 2014 Jun; 60(6):1225-34. PubMed ID: 24607627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
